← Eichor
Study identifier: NCT06478407 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Community Screening Study of Diabetic Retinopathy in Tianjin in 2024

Condition: Diabetic Retinopathy  ·  Sponsor: Li Xiaorong

PhaseN/A
Planned participants18000
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersYes

About this study

Through this study, the investigators hope to understand the prevalence and influencing factors of diabetic retinopathy in Tianjin, improve the ability of complication detection and intervention in diabetic patients in primary medical and health institutions, and build a diabetes prevention and treatment network. The investigators should adhere to the policy of prevention first, combined with prevention and control, and explore a diabetes' prevention and control model suitable for our city. Extensive publicity and education should be carried out to improve the awareness of self-management ,improve the screening rate of diabetic retinopathy, and reduce the blindness rate.

This description comes directly from the study's public registry record.

Talk to the study team

Juping Liu, Director  ·  13752033227  ·  tydljp@126.com

Always discuss trial participation with your own doctor first.

Locations (1)

Tianjin Medical University Eye HospitalTianjin, Tianjin Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06478407